What is the HCAT stock price prediction for next 2 weeks?

According to our price prediction algorithm,Health Catalyst, Inc. (HCAT) price will be around $1.21 in the next 2 weeks. This means it will decrease by -10.037313432835825 from the last closing price. This prediction may vary from other time period filters for HCAT stock.

What can be the highest Possible price of HCAT stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, HCAT can achieve the highest price of $1.49 which is 10.917101447981116 higher than last closing price. This prediction may vary from other time period filters for HCAT stock.

What can be the lowest Possible price of HCAT stock in next 2 weeks?

As per the forecast and algorithmic analysis, HCAT stock price can be as low as $0.92 which is -31.633554674735194 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for HCAT stock.

Will HCAT stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that HCAT stock will lose-10.037313432835825 in the next 2 weeks. This prediction may vary from other time period filters for HCAT stock.

What is HCAT stock last closing price?

Last closing price of HCAT stock was $1.27.

What is HCAT stock price prediction?

HCAT stock price prediction means predicting the future closing prices of HCAT stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of HCAT stock in a certain time period.

How we predict HCAT stock future prices?

If you are searching for HCAT stock forecast, analysis or price prediction, then you might be wondering what Health Catalyst, Inc. (HCAT) will do in the future. Our HCAT price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This HCAT price prediction will likely answer most of your questions.

How frequent we update HCAT stock predictions?

We are updating the forecasts for the HCAT stock on daily basis.

Is using ML forecasting for HCAT stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for HCAT stock same for all the time periods?

No, the prediction for HCAT stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Health Catalyst, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$1.2713.39%Since 2 Weeks

Predicted Price$1.21-10.04%For 2 Weeks

Upper Predicted Price$1.4910.92%For 2 Weeks

Lower Predicted Price$0.92-31.63%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of HCAT will decline by -10.04% over the next 2 Weeks and hit $1.21 by Tuesday, May 12, 2026. In that time frame, HCAT's share price is expected to range between $0.92 and $1.49.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
May 12, 2026	0.92	1.21	1.49
May 11, 2026	0.93	1.21	1.48
May 8, 2026	0.97	1.22	1.51
May 7, 2026	1.03	1.30	1.56
May 6, 2026	0.97	1.24	1.50
May 5, 2026	1.01	1.28	1.57
May 4, 2026	1.01	1.28	1.57
May 1, 2026	1.04	1.30	1.56
Apr 30, 2026	1.09	1.38	1.66
Apr 29, 2026	1.03	1.31	1.58

HCAT shares fell -5.22% in Wednesday, April 29, 2026's trading session, dropping from a previous close of $1.34 to move at $1.27. The stock demonstrated notable intraday movement (see HCAT's key stats for a full breakdown), fluctuating between $1.26 and $1.39, a +10.36% trading range. While recent weeks have seen some volatility, HCAT has managed to secure a +13.39% gain over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 300.61K shares changing hands, 526.74K fewer than the previous session. This amounted to $381.77K in total market activity.

Will HCAT Continue Its Upward Trend?

According to analyst ratings and projections for HCAT, Health Catalyst, Inc. shares are anticipated to increase by +14.55%, potentially reaching $1.49 per share by May 12, 2026. Short-term technical indicators currently suggest a neutral sentiment for HCAT. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 12 positive trading days within the past 30 sessions. Based on the HCAT stock forecast, now is a good time to buy HCAT stock because its current trading price is +5.35% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on HCAT covering social and institutional perspectives.

HCAT Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into HCAT's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 45.28% to 49.33%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 41.82%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 42.59%, maintains a neutral outlook for the long term. Insights into HCAT's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Health Catalyst Short-Term Forecasts

HCAT Forecast For Next 5 Days

Our algorithm anticipates Health Catalyst (HCAT) stock could hit $1.20 by May 06, 2026. This represents a -5.49% fall from today's price, following a -10.16% change over the past five days.

HCAT Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Health Catalyst, Inc. (HCAT) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $1.03, which would mean a -18.90% decrease from the current price of $1.27. Projections for this period range from a high of $1.56 to a low of $0.55.

HCAT Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Health Catalyst's price over the next three months point to a rise. HCAT stock is expected to peak at $3.90 on Jun 16, 2026 before potentially dipping to $2.95 on Jul 09, 2026. On average, HCAT is likely to trade around $3.40 in the coming 90 days.

Health Catalyst Stock Forecast 2025

Based on our predictive models, Health Catalyst (HCAT) is expected to trade between $0.00 and $3.90 throughout 2026. This would result in an average price of $2.88, potentially offering investors a +126.77% return from current levels.

Health Catalyst, Inc. Monthly Forecast 2026–2027

April 2026

According to our latest forecast models, Health Catalyst, Inc. (HCAT) is positioned to show a strong performance in April 2026. The price is predicted to move between $3.07 and $3.36, settling at an average of $3.21. This could translate to a +152.76% gain.

May 2026

Based on current market signals, Health Catalyst, Inc. is projected to trend may 2026. We forecast a trading range from $3.07 to $3.44, with a likely average price of $3.24. Investors could expect a potential return of +155.12%.

June 2026

Our predictive algorithms indicate Health Catalyst, Inc. stock may see a shift in June 2026. The expected range spans $3.13–$3.90, with an average target of $3.50. This represents a positive outlook and a possible gain of +175.59%.

July 2026

Analyzing established trends, Health Catalyst, Inc. looks set to move in July 2026. Projections place the stock between $2.95 and $3.87, averaging around $3.48. This suggests a +174.02% gain from current levels.

August 2026

Market indicators suggest Health Catalyst, Inc. could experience notable changes during August 2026. Prices could fluctuate within $2.28 to $3.73, with a midpoint forecast of $3.18. The stock might deliver a +150.39% gain.

September 2026

Forecasting for September 2026, models estimate that Health Catalyst, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $1.58 and $2.96, averaging $2.61. This signals a positive trajectory with potential returns around +105.51%.

October 2026

According to our latest forecast models, Health Catalyst, Inc. (HCAT) is positioned to show a strong performance in October 2026. The price is predicted to move between $1.02 and $2.52, settling at an average of $2.40. This could translate to a +88.98% gain.

November 2026

Based on current market signals, Health Catalyst, Inc. is projected to trend november 2026. We forecast a trading range from $0.37 to $2.14, with a likely average price of $2.35. Investors could expect a potential return of +85.04%.

December 2026

Our predictive algorithms indicate Health Catalyst, Inc. stock may see a shift in December 2026. The expected range spans $0.00–$1.71, with an average target of $2.22. This represents a positive outlook and a possible gain of +74.80%.

January 2027

Analyzing established trends, Health Catalyst, Inc. looks set to move in January 2027. Projections place the stock between $0.00 and $1.22, averaging around $2.01. This suggests a +58.27% gain from current levels.

February 2027

Market indicators suggest Health Catalyst, Inc. could experience notable changes during February 2027. Prices could fluctuate within $0.00 to $0.47, with a midpoint forecast of $1.50. The stock might deliver a +18.11% gain.

March 2027

Forecasting for March 2027, models estimate that Health Catalyst, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.00, averaging $1.23. This signals a cautious trajectory with potential returns around -3.15%.

April 2027

According to our latest forecast models, Health Catalyst, Inc. (HCAT) is positioned to show a strong performance in April 2027. The price is predicted to move between $0.00 and $0.00, settling at an average of $1.14. This could translate to a -10.24% loss.

HCAT's history of dividends and stock splits also plays a role in long-term investor confidence.